SCHEMBL23360516

SCHEMBL23360516

O=C(O)N1CCC(Nc2ccnc3c(F)cccc23)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 4/20 0.43
PRKD3 O94806 2/20 0.43
MAP4K4 O95819 2/20 0.43
CDK1 P06493 2/20 0.43
CSF1R P07333 2/20 0.43
FLT4 P35916 2/20 0.43
CLK2 P49760 2/20 0.43
MAPK12 P53778 2/20 0.43
CSNK2A1 P68400 2/20 0.43
CDK5 Q00535 2/20 0.43
STK3 Q13188 2/20 0.43
TAOK1 Q7L7X3 2/20 0.43
PIM3 Q86V86 2/20 0.43
HIPK4 Q8NE63 2/20 0.43
AURKB Q96GD4 2/20 0.43
HIPK2 Q9H2X6 2/20 0.43
CLK4 Q9HAZ1 2/20 0.43
CDC7 O00311 1/20 0.43
AURKA O14965 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23360514 1.00 CDK2 (0.43) CDK2PRKD3MAP4K4CDK1CSF1R
SCHEMBL23360161 0.91 KDM4E (0.40) CDK2CCNKCCNA2CDK7CCNH
SCHEMBL23360172 0.91 KDM4E (0.40) CDK2CCNKCCNA2CDK7CCNH
SCHEMBL23360158 0.91 KDM4E (0.40) CDK2CCNKCCNA2CDK7CCNH
SCHEMBL23360026 0.87 JAK3 (0.42) CDK2MAP4K4CSNK2A1HIPK4CLK4
SCHEMBL23360592 0.87 HTR1A (0.46) MAPK1PIM1PIM2JAK3BTK
SCHEMBL23360023 0.87 JAK3 (0.42) CDK2MAP4K4CSNK2A1HIPK4CLK4
SCHEMBL23360595 0.87 HTR1A (0.46) MAPK1PIM1PIM2JAK3BTK
SCHEMBL23360467 0.86 GSK3A (0.46) CDK2PRKD3MAP4K4CDK1FLT4
SCHEMBL23360464 0.86 GSK3A (0.46) CDK2PRKD3MAP4K4CDK1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL CDK2 1830/4885PRKD3 1439/4885MAP4K4 2302/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL CDK2 1830/4885PRKD3 1439/4885MAP4K4 2302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.